You are here

ACS CAN/AdvaMedDx Personalized Medicine Roundtables - Pennsylvania

November 3, 2015
Independent Blue Cross Corporate Office
Person

AdvaMedDx partnered with the American Cancer Society Cancer Action Network (ACS CAN) to host a series of state-based personalized medicine roundtable events in order to bring attention to the role of diagnostics and personalized medicine in oncology. Five events were held between August and November 2015:

Attendance: 59

Event Summary:

Presentations and discussion focused on the new era of personalized medicine, barriers to implementation and how policies can be created to make sure that patients have access to these new therapies.

Moderator:

  • Dr. Donald Liss, Vice President Clinical Programs and Policy, Independence Blue Cross

Panel Speakers:

  • Dr. Wafik El-Deiry, Deputy Cancer Center Director for Translational Research, Fox Chase Cancer Center
  • Mr. William A. Faucett, Directory of Policy & Education, Office of the CSO, Geisinger Health System
  • Ms. Vivian Coates, Vice President Information Services & Health Technology Assessment, ECRI Institute
  • Ms. Vivian Pacheco, Director Global Marketing Oncology Companion Diagnostics, Janssen Diagnostics
  • Dr. David Roth, Simon Flexner Professor of Pathology and Laboratory Medicine, Penn Medicine
  • Mr. William Kevin Kelly, Professor Sidney Kimmel Cancer Center, Thomas Jefferson University